References
- Picchioni MM , MurrayRM. Schizophrenia. BMJ335(7610) , 91–95 (2007).
- Buckley PF , MillerBJ, LehrerDS, CastleDJ. Psychiatric comorbidities and schizophrenia. Schizophr. Bull.35(2) , 383–402 (2009).
- Lin E , TsaiSJ. Gene–gene interactions in a context of individual variability in antipsychotic drug pharmacogenomics. Curr. Pharm. Pers. Med.9(4) , 323–331 (2011).
- van Os J , KapurS. Schizophrenia. Lancet374(9690) , 635–645 (2009).
- Lane HY , LeeCC, LiuYC, ChangWH. Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics. Pharmacogenomics6(2) , 139–149 (2005).
- Cacabelos R , HashimotoR, TakedaM. Pharmacogenomics of antipsychotics efficacy for schizophrenia. Psychiatry Clin. Neurosci.65(1) , 3–19 (2011).
- Lin E , TsaiSJ. Novel diagnostics R&D for public health and personalized medicine in Taiwan: current state, challenges and opportunities. Curr. Pharm. Pers. Med.10(3) , 239–246 (2012).
- Lin E . Novel drug therapies and diagnostics for personalized medicine and nanomedicine in genome science, nanoscience, and molecular engineering. Pharmaceut. Regul. Aff.: Open Access1 , e116 (2012).
- Gonçalves VF , ZaiCC, TiwariAK et al. A hypothesis driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia. Neuropsychopharmacology doi:10.1038/npp.2013.312 (2013) (Epub ahead of print).
References
- Kuzman MR , MüllerDJ. Association of the MTHFR gene with antipsychotic-induced metabolic abnormalities in patients with schizophrenia. Pharmacogenomics13(8) , 843–846 (2012).
- Srisawat U , ReynoldsGP, ZhangZJ et al. Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia. Int. J. Neuropsychopharmacol. 17(3) , 485–490 (2013)
References
- Lane HY , LeeCC, LiuYC, ChangWH. Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics. Pharmacogenomics6(2) , 139–149 (2005).
- Cacabelos R , HashimotoR, TakedaM. Pharmacogenomics of antipsychotics efficacy for schizophrenia. Psychiatry Clin. Neurosci.65(1) , 3–19 (2011).
- Lin E , TsaiSJ. Novel diagnostics R&D for public health and personalized medicine in Taiwan: current state, challenges and opportunities. Curr. Pharm. Pers. Med.10(3) , 239–246 (2012).
- Lin E . Novel drug therapies and diagnostics for personalized medicine and nanomedicine in genome science, nanoscience, and molecular engineering. Pharmaceut. Regul. Aff.: Open Access1 , e116 (2012).
- Zivković M , Mihaljevic-PelesA, BozinaN et al. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol. J. Clin. Psychopharmacol. 33(5) , 593–599 (2013).